Literature DB >> 19651616

Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests.

Aiqi Fang1, Donald F Gerson, Arnold L Demain.   

Abstract

In the hope of developing a vaccine against Clostridium difficile based on its toxin(s), we have developed a fermentation medium for the bacterium that results in the formation of Toxin A and contains no meat or dairy products, thus obviating the problem of possible prion diseases. Particular preparations of hydrolyzed soy proteins, especially Soy Peptone A3, have been found to replace both the meat/dairy product tryptone in the preparation of working cell banks and seed media, and NZ-Soy BL4 does the same in the fermentation medium. These replacements yield even higher toxin titers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651616      PMCID: PMC2716386          DOI: 10.1073/pnas.0906425106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  The classification of Bacteroides melaninogenicus and related species.

Authors:  W P Holbrook; B I Duerden; A G Deacon
Journal:  J Appl Bacteriol       Date:  1977-04

2.  Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (e.g., brain heart infusion) and dairy proteins or digests (e.g., casein hydrolysates).

Authors:  Arnold L Demain; Donald F Gerson; Aiqi Fang
Journal:  Vaccine       Date:  2005-11-16       Impact factor: 3.641

3.  Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor.

Authors:  N Mani; B Dupuy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Tetanus toxin production in soy-based medium: nutritional studies and scale-up into small fermentors.

Authors:  A L Demain; S George; M Kole; D F Gerson; A Fang
Journal:  Lett Appl Microbiol       Date:  2007-10-01       Impact factor: 2.858

5.  The Use of Reduced Iron for the Cultivation of Anaerobic Organisms.

Authors:  J P Scott; C A Brandly
Journal:  J Bacteriol       Date:  1933-07       Impact factor: 3.490

6.  Regulated transcription of Clostridium difficile toxin genes.

Authors:  B Dupuy; A L Sonenshein
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

7.  Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids.

Authors:  Sture Karlsson; Lars G Burman; Thomas Åkerlund
Journal:  Microbiology       Date:  1999-07       Impact factor: 2.777

8.  The distribution of Clostridium difficile in the environment of South Wales.

Authors:  N al Saif; J S Brazier
Journal:  J Med Microbiol       Date:  1996-08       Impact factor: 2.472

9.  Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation.

Authors:  A B Onderdonk; B R Lowe; J G Bartlett
Journal:  Appl Environ Microbiol       Date:  1979-10       Impact factor: 4.792

10.  Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene.

Authors:  T Garnier; S T Cole
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

View more
  9 in total

1.  Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.

Authors:  Melinda A Engevik; Kristen A Engevik; Mary Beth Yacyshyn; Jiang Wang; Daniel J Hassett; Benjamin Darien; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

2.  Human Clostridium difficile infection: altered mucus production and composition.

Authors:  Melinda A Engevik; Mary Beth Yacyshyn; Kristen A Engevik; Jiang Wang; Benjamin Darien; Daniel J Hassett; Bruce R Yacyshyn; Roger T Worrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-31       Impact factor: 4.052

3.  Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Authors:  Raphael S Rodrigues; Renato A C Oliveira; Yuesheng Li; Snjezana Zaja-Milatovic; Lourrany B Costa; Manuel B Braga Neto; Glynis L Kolling; Aldo A Lima; Richard L Guerrant; Cirle Alcantara Warren
Journal:  J Infect Dis       Date:  2013-01-28       Impact factor: 5.226

4.  The membrane as a target for controlling hypervirulent Clostridium difficile infections.

Authors:  Xiaoqian Wu; Philip T Cherian; Richard E Lee; Julian G Hurdle
Journal:  J Antimicrob Chemother       Date:  2012-12-21       Impact factor: 5.790

5.  The SOS Response Master Regulator LexA Is Associated with Sporulation, Motility and Biofilm Formation in Clostridium difficile.

Authors:  Beata M Walter; Stephen T Cartman; Nigel P Minton; Matej Butala; Maja Rupnik
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

6.  CD25890, a conserved protein that modulates sporulation initiation in Clostridioides difficile.

Authors:  Diogo Martins; Michael A DiCandia; Aristides L Mendes; Daniela Wetzel; Shonna M McBride; Adriano O Henriques; Mónica Serrano
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.996

7.  A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.

Authors:  Robert G K Donald; Mike Flint; Narender Kalyan; Erik Johnson; Susan E Witko; Cheryl Kotash; Ping Zhao; Shakuntala Megati; Irina Yurgelonis; Phillip Kwok Lee; Yury V Matsuka; Elena Severina; Anne Deatly; Mini Sidhu; Kathrin U Jansen; Nigel P Minton; Annaliesa S Anderson
Journal:  Microbiology (Reading)       Date:  2013-04-29       Impact factor: 2.777

8.  Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae.

Authors:  Allison E B Turner; Jonas E Gerson; Helen Y So; Daniel J Krasznai; Adrienne J St Hilaire; Donald F Gerson
Journal:  Synth Syst Biotechnol       Date:  2017-01-20

9.  Systematic Evaluation of Parameters Important for Production of Native Toxin A and Toxin B from Clostridioides difficile.

Authors:  Aria Aminzadeh; René Jørgensen
Journal:  Toxins (Basel)       Date:  2021-03-27       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.